相关实验视频

Updated: Jun 13, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

TNFSF12与乳腺癌预后和免疫细胞透有关

Jinling Chen¹, Yahui She¹, Chunbo Feng²

¹Department of Blood Transfusion, The Affiliated Bozhou Hospital of Anhui Medical University Bozhou 236800, Anhui, China.

American journal of translational research

|September 12, 2024

概括

乳腺癌 (BRCA) 中TNFSF12的低表达与生存率差和免疫细胞透的改变相关. 这一发现突出了TNFSF12作为BRCA预后和治疗反应的潜在生物标志物.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

乳腺癌 (BRCA) 是女性癌症相关死亡的主要原因.
作为TNF超级家族的成员,TNFSF12与各种癌症有关,但其在BRCA进展中的作用尚不清楚.

研究的目的:

为了研究BRCA中TNFSF12的表达特征.
检查TNFSF12与预后,免疫细胞透和对BRCA治疗的反应的关联.

主要方法:

利用癌症基因组图谱 (TCGA) 数据库进行表达和临床数据分析.
进行了功能性丰富分析,免疫细胞透评估和ELISA蛋白质水平.
评估了与免疫检查点抑制剂 (ICI) 和化疗反应的相关性.

主要成果:

发现TNFSF12在BRCA表达低,与整体存活率差相关,特别是在HER2阳性患者中.
高TNFSF12表达与各种免疫细胞的透增加以及对免疫检查点抑制剂的敏感性相关.
功能分析显示基于TNFSF12表达水平的不同信号通路激活和抑制,观察到不同的化疗敏感性.

结论:

在BRCA患者中,TNFSF12表达与预后和免疫反应密切相关.
TNFSF12可以作为乳腺癌治疗有效性的预测生物标志物.

关键词:

乳腺癌是什么? 乳腺癌是什么在TNFSF12中使用.化学疗法化疗化疗免疫检查点的检查点.

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...